PARADEEP2023-10-012023-12-31 PARADEEP2023-10-012023-12-31 PARADEEP2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member PARADEEP2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member PARADEEP2023-12-31 PARADEEP2023-10-012023-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PARADEEP2023-10-012023-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PARADEEP2023-10-012023-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PARADEEP2023-10-012023-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543530 PARADEEP NOTLISTED Paradeep Phosphates Limited Equity 2023-04-01 2024-03-31 2024-02-05 2024-01-25 INR Crores Third quarter 14:30:00 16:05:00 2024-02-05 2024-02-05 Not applicable Single segment FERTILIZER 2023-10-01 2023-12-31 Unaudited Consolidated 25950300000.00 86400000.00 26036700000.00 16110000000.00 2077300000.00 522500000.00 558600000.00 824600000.00 551600000.00 3857000000.00 24501600000.00 1535100000.00 0.00 1535100000.00 48400000.00 397500000.00 445900000.00 0.00 1089200000.00 0.00 0.00 0.00 0.00 1089200000.00 -10700000.00 1078500000.00 0.00 0.00 0.00 0.00 8147000000.00 10 1.33 1.33 0.00 0.00 1.33 1.33 0.00 0.00 0.00 Notes 1. The above consolidated financial results were reviewed by the audit committee and approved by the Board of Directors in their respective meetings held on 5 February 2024. The limited review of these consolidated financial results, as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 has been completed by the statutory auditors of the Company. 2. The Company’s operations fall within a single business segment “Fertilisers and Other Trading Materials”. Hence, no separate segment information is disclosed. 3.On 1 June 2022, the Company completed the acquisition of Goa plant and allied business of Zuari Agro Chemicals Limited (ZACL) on a slump sale basis. The above financial results for the nine months period ended 31 December 2022 include the results of the acquired business for the period starting from 1 June 2022 and hence are not comparable with the other periods presented. Single segment 2023-04-01 2023-12-31 Unaudited Consolidated 93323800000.00 388100000.00 93711900000.00 60714900000.00 10395900000.00 2377400000.00 1719100000.00 2707600000.00 1528600000.00 13117200000.00 92560700000.00 1151200000.00 0.00 1151200000.00 48400000.00 313400000.00 361800000.00 0.00 789400000.00 0.00 0.00 0.00 -5300000.00 784100000.00 -4300000.00 779800000.00 0.00 0.00 0.00 0.00 8147000000.00 10 0.96 0.96 0.00 0.00 0.96 0.96 0.01 0.01 0.01 Other Expenses 3857000000.00 Other Expenses 13117200000.00 Re-measurement gains/(losses) on defined benefit plans -15000000.00 Re-measurement gains/(losses) on defined benefit plans -13900000.00 -15000000.00 -13900000.00 -3800000.00 -3500000.00 Exchange differences on translation of foreign operations 500000.00 Exchange differences on translation of foreign operations 6100000.00 500000.00 6100000.00 0.00 0.00